Outcome of Upfront Surgically Resected Patients of Oral Tongue Squamous Cell Carcinoma and Factors Affecting it: Experience from Tertiary Care Facility in North India

Oral tongue squamous cell carcinoma (OTSCC) is the most aggressive subsite among oral cancers. The poor survival rate has been primarily attributed to high loco-regional recurrence. Two recent developments viz. incorporation depth of invasion (DOI) in American Joint Committee on Cancer (AJCC) TNM 8t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Indian journal of otolaryngology, and head, and neck surgery and head, and neck surgery, 2024-10, Vol.76 (5), p.4479-4486
Hauptverfasser: Jain, Sumeet, Dhall, Kunal, Brar, Gurpreet Singh, Gupta, Sumit, Jain, Kunal, Garg, Nitish, Sood, Sandhya, Aggarwal, Ritu, Sidhu, Manjinder
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4486
container_issue 5
container_start_page 4479
container_title Indian journal of otolaryngology, and head, and neck surgery
container_volume 76
creator Jain, Sumeet
Dhall, Kunal
Brar, Gurpreet Singh
Gupta, Sumit
Jain, Kunal
Garg, Nitish
Sood, Sandhya
Aggarwal, Ritu
Sidhu, Manjinder
description Oral tongue squamous cell carcinoma (OTSCC) is the most aggressive subsite among oral cancers. The poor survival rate has been primarily attributed to high loco-regional recurrence. Two recent developments viz. incorporation depth of invasion (DOI) in American Joint Committee on Cancer (AJCC) TNM 8th edition and elective neck dissection in clinically negative neck have potential to improve survival. We in our study have tried to look at overall survival and factors affecting patients of only OTSCC. 144 patients of OTSCC operated upfront between July 2017 and December 2023 were included in our study. Selective neck dissection was done in all patients with clinically negative neck. T staging was done using both AJCC TNM 7th and 8th edition. Primary objective of the study was to determine the overall survival and factors affecting it. The secondary objectives were to determine the disease-free survival and to look at the effect of forementioned new developments in patients in OTSCC. Mean overall survival and disease-free survival in our study cohort was 48.8 months and 48.3 months respectively in follow up period ranging from 2 months to 75 months. DOI > 10 millimetres and involved margins were factors significantly associated with survival on multivariate analysis. Lymph node metastasis was detected in 32(35.2%) patients out of 91 patients with clinically negative neck and 31(21.6%) of patients were upstaged from T1/T2 in AJCC TNM 7th to T3/T4 according to AJCC TNM 8th edition. The 5-years overall survival of our patients was about 54% with nearly half of our patients presenting in stage III and stage IV. There is need to create awareness in general population as the impact of the new changes will only be seen if patients present at an early stage.
doi_str_mv 10.1007/s12070-024-04889-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3114153795</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3114153795</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-6ddf35a005b5b5d498e7c13ea97fdfcc1098b887c6825000635b32f725e7668d3</originalsourceid><addsrcrecordid>eNp9kcFu1DAURS1ERaeFH2CBLLFhE_psJ3HCrhq1tFLVQXS6jjzO8-Aqsae2I3V-iO_EYQpIXSAvvPC5973rS8h7Bp8ZgDyLjIOEAnhZQNk0bQGvyAJaKQopQb4mC84FK4Rs62NyEuMDgKiYhDfkWLRC1qIuF-Tnakraj0i9ofc7E7xL9G4KW6vVMOzpd4yoE_b0m0oWXYoztwpqoGvvthPSu8dJjX6KdInDQJcqaOv8qKhyPb1UOvkQ6bkx2cS6LbXpC7142mHIXhppHjfSNYZkVdjPYpw1drBpT62jtz6kH_Ta9Va9JUdGDRHfPd-n5P7yYr28Km5WX6-X5zeF5lWdirrvjagUQLXJpy_bBqVmAlUrTW-0ZtA2m6aRum54BQC1qDaCG8krlHXd9OKUfDr47oJ_nDCmbrRR52jKYU7ZCcZKVuUvrTL68QX64Kfg8nYzJYRknDWZ4gdKBx9jQNPtgh1z3I5BN7fYHVrscovd7xY7yKIPz9bTZsT-r-RPbRkQByDmJ7fF8G_2f2x_ARPaqL4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3113371218</pqid></control><display><type>article</type><title>Outcome of Upfront Surgically Resected Patients of Oral Tongue Squamous Cell Carcinoma and Factors Affecting it: Experience from Tertiary Care Facility in North India</title><source>SpringerLink Journals - AutoHoldings</source><creator>Jain, Sumeet ; Dhall, Kunal ; Brar, Gurpreet Singh ; Gupta, Sumit ; Jain, Kunal ; Garg, Nitish ; Sood, Sandhya ; Aggarwal, Ritu ; Sidhu, Manjinder</creator><creatorcontrib>Jain, Sumeet ; Dhall, Kunal ; Brar, Gurpreet Singh ; Gupta, Sumit ; Jain, Kunal ; Garg, Nitish ; Sood, Sandhya ; Aggarwal, Ritu ; Sidhu, Manjinder</creatorcontrib><description>Oral tongue squamous cell carcinoma (OTSCC) is the most aggressive subsite among oral cancers. The poor survival rate has been primarily attributed to high loco-regional recurrence. Two recent developments viz. incorporation depth of invasion (DOI) in American Joint Committee on Cancer (AJCC) TNM 8th edition and elective neck dissection in clinically negative neck have potential to improve survival. We in our study have tried to look at overall survival and factors affecting patients of only OTSCC. 144 patients of OTSCC operated upfront between July 2017 and December 2023 were included in our study. Selective neck dissection was done in all patients with clinically negative neck. T staging was done using both AJCC TNM 7th and 8th edition. Primary objective of the study was to determine the overall survival and factors affecting it. The secondary objectives were to determine the disease-free survival and to look at the effect of forementioned new developments in patients in OTSCC. Mean overall survival and disease-free survival in our study cohort was 48.8 months and 48.3 months respectively in follow up period ranging from 2 months to 75 months. DOI &gt; 10 millimetres and involved margins were factors significantly associated with survival on multivariate analysis. Lymph node metastasis was detected in 32(35.2%) patients out of 91 patients with clinically negative neck and 31(21.6%) of patients were upstaged from T1/T2 in AJCC TNM 7th to T3/T4 according to AJCC TNM 8th edition. The 5-years overall survival of our patients was about 54% with nearly half of our patients presenting in stage III and stage IV. There is need to create awareness in general population as the impact of the new changes will only be seen if patients present at an early stage.</description><identifier>ISSN: 2231-3796</identifier><identifier>EISSN: 0973-7707</identifier><identifier>DOI: 10.1007/s12070-024-04889-0</identifier><identifier>PMID: 39376364</identifier><language>eng</language><publisher>New Delhi: Springer India</publisher><subject>Head and Neck Surgery ; Medicine ; Medicine &amp; Public Health ; Oral cancer ; Original Article ; Otorhinolaryngology ; Squamous cell carcinoma</subject><ispartof>Indian journal of otolaryngology, and head, and neck surgery, 2024-10, Vol.76 (5), p.4479-4486</ispartof><rights>Association of Otolaryngologists of India 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-6ddf35a005b5b5d498e7c13ea97fdfcc1098b887c6825000635b32f725e7668d3</cites><orcidid>0000-0003-0884-7401</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12070-024-04889-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12070-024-04889-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39376364$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jain, Sumeet</creatorcontrib><creatorcontrib>Dhall, Kunal</creatorcontrib><creatorcontrib>Brar, Gurpreet Singh</creatorcontrib><creatorcontrib>Gupta, Sumit</creatorcontrib><creatorcontrib>Jain, Kunal</creatorcontrib><creatorcontrib>Garg, Nitish</creatorcontrib><creatorcontrib>Sood, Sandhya</creatorcontrib><creatorcontrib>Aggarwal, Ritu</creatorcontrib><creatorcontrib>Sidhu, Manjinder</creatorcontrib><title>Outcome of Upfront Surgically Resected Patients of Oral Tongue Squamous Cell Carcinoma and Factors Affecting it: Experience from Tertiary Care Facility in North India</title><title>Indian journal of otolaryngology, and head, and neck surgery</title><addtitle>Indian J Otolaryngol Head Neck Surg</addtitle><addtitle>Indian J Otolaryngol Head Neck Surg</addtitle><description>Oral tongue squamous cell carcinoma (OTSCC) is the most aggressive subsite among oral cancers. The poor survival rate has been primarily attributed to high loco-regional recurrence. Two recent developments viz. incorporation depth of invasion (DOI) in American Joint Committee on Cancer (AJCC) TNM 8th edition and elective neck dissection in clinically negative neck have potential to improve survival. We in our study have tried to look at overall survival and factors affecting patients of only OTSCC. 144 patients of OTSCC operated upfront between July 2017 and December 2023 were included in our study. Selective neck dissection was done in all patients with clinically negative neck. T staging was done using both AJCC TNM 7th and 8th edition. Primary objective of the study was to determine the overall survival and factors affecting it. The secondary objectives were to determine the disease-free survival and to look at the effect of forementioned new developments in patients in OTSCC. Mean overall survival and disease-free survival in our study cohort was 48.8 months and 48.3 months respectively in follow up period ranging from 2 months to 75 months. DOI &gt; 10 millimetres and involved margins were factors significantly associated with survival on multivariate analysis. Lymph node metastasis was detected in 32(35.2%) patients out of 91 patients with clinically negative neck and 31(21.6%) of patients were upstaged from T1/T2 in AJCC TNM 7th to T3/T4 according to AJCC TNM 8th edition. The 5-years overall survival of our patients was about 54% with nearly half of our patients presenting in stage III and stage IV. There is need to create awareness in general population as the impact of the new changes will only be seen if patients present at an early stage.</description><subject>Head and Neck Surgery</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oral cancer</subject><subject>Original Article</subject><subject>Otorhinolaryngology</subject><subject>Squamous cell carcinoma</subject><issn>2231-3796</issn><issn>0973-7707</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kcFu1DAURS1ERaeFH2CBLLFhE_psJ3HCrhq1tFLVQXS6jjzO8-Aqsae2I3V-iO_EYQpIXSAvvPC5973rS8h7Bp8ZgDyLjIOEAnhZQNk0bQGvyAJaKQopQb4mC84FK4Rs62NyEuMDgKiYhDfkWLRC1qIuF-Tnakraj0i9ofc7E7xL9G4KW6vVMOzpd4yoE_b0m0oWXYoztwpqoGvvthPSu8dJjX6KdInDQJcqaOv8qKhyPb1UOvkQ6bkx2cS6LbXpC7142mHIXhppHjfSNYZkVdjPYpw1drBpT62jtz6kH_Ta9Va9JUdGDRHfPd-n5P7yYr28Km5WX6-X5zeF5lWdirrvjagUQLXJpy_bBqVmAlUrTW-0ZtA2m6aRum54BQC1qDaCG8krlHXd9OKUfDr47oJ_nDCmbrRR52jKYU7ZCcZKVuUvrTL68QX64Kfg8nYzJYRknDWZ4gdKBx9jQNPtgh1z3I5BN7fYHVrscovd7xY7yKIPz9bTZsT-r-RPbRkQByDmJ7fF8G_2f2x_ARPaqL4</recordid><startdate>202410</startdate><enddate>202410</enddate><creator>Jain, Sumeet</creator><creator>Dhall, Kunal</creator><creator>Brar, Gurpreet Singh</creator><creator>Gupta, Sumit</creator><creator>Jain, Kunal</creator><creator>Garg, Nitish</creator><creator>Sood, Sandhya</creator><creator>Aggarwal, Ritu</creator><creator>Sidhu, Manjinder</creator><general>Springer India</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0884-7401</orcidid></search><sort><creationdate>202410</creationdate><title>Outcome of Upfront Surgically Resected Patients of Oral Tongue Squamous Cell Carcinoma and Factors Affecting it: Experience from Tertiary Care Facility in North India</title><author>Jain, Sumeet ; Dhall, Kunal ; Brar, Gurpreet Singh ; Gupta, Sumit ; Jain, Kunal ; Garg, Nitish ; Sood, Sandhya ; Aggarwal, Ritu ; Sidhu, Manjinder</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-6ddf35a005b5b5d498e7c13ea97fdfcc1098b887c6825000635b32f725e7668d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Head and Neck Surgery</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oral cancer</topic><topic>Original Article</topic><topic>Otorhinolaryngology</topic><topic>Squamous cell carcinoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jain, Sumeet</creatorcontrib><creatorcontrib>Dhall, Kunal</creatorcontrib><creatorcontrib>Brar, Gurpreet Singh</creatorcontrib><creatorcontrib>Gupta, Sumit</creatorcontrib><creatorcontrib>Jain, Kunal</creatorcontrib><creatorcontrib>Garg, Nitish</creatorcontrib><creatorcontrib>Sood, Sandhya</creatorcontrib><creatorcontrib>Aggarwal, Ritu</creatorcontrib><creatorcontrib>Sidhu, Manjinder</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Indian journal of otolaryngology, and head, and neck surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jain, Sumeet</au><au>Dhall, Kunal</au><au>Brar, Gurpreet Singh</au><au>Gupta, Sumit</au><au>Jain, Kunal</au><au>Garg, Nitish</au><au>Sood, Sandhya</au><au>Aggarwal, Ritu</au><au>Sidhu, Manjinder</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcome of Upfront Surgically Resected Patients of Oral Tongue Squamous Cell Carcinoma and Factors Affecting it: Experience from Tertiary Care Facility in North India</atitle><jtitle>Indian journal of otolaryngology, and head, and neck surgery</jtitle><stitle>Indian J Otolaryngol Head Neck Surg</stitle><addtitle>Indian J Otolaryngol Head Neck Surg</addtitle><date>2024-10</date><risdate>2024</risdate><volume>76</volume><issue>5</issue><spage>4479</spage><epage>4486</epage><pages>4479-4486</pages><issn>2231-3796</issn><eissn>0973-7707</eissn><abstract>Oral tongue squamous cell carcinoma (OTSCC) is the most aggressive subsite among oral cancers. The poor survival rate has been primarily attributed to high loco-regional recurrence. Two recent developments viz. incorporation depth of invasion (DOI) in American Joint Committee on Cancer (AJCC) TNM 8th edition and elective neck dissection in clinically negative neck have potential to improve survival. We in our study have tried to look at overall survival and factors affecting patients of only OTSCC. 144 patients of OTSCC operated upfront between July 2017 and December 2023 were included in our study. Selective neck dissection was done in all patients with clinically negative neck. T staging was done using both AJCC TNM 7th and 8th edition. Primary objective of the study was to determine the overall survival and factors affecting it. The secondary objectives were to determine the disease-free survival and to look at the effect of forementioned new developments in patients in OTSCC. Mean overall survival and disease-free survival in our study cohort was 48.8 months and 48.3 months respectively in follow up period ranging from 2 months to 75 months. DOI &gt; 10 millimetres and involved margins were factors significantly associated with survival on multivariate analysis. Lymph node metastasis was detected in 32(35.2%) patients out of 91 patients with clinically negative neck and 31(21.6%) of patients were upstaged from T1/T2 in AJCC TNM 7th to T3/T4 according to AJCC TNM 8th edition. The 5-years overall survival of our patients was about 54% with nearly half of our patients presenting in stage III and stage IV. There is need to create awareness in general population as the impact of the new changes will only be seen if patients present at an early stage.</abstract><cop>New Delhi</cop><pub>Springer India</pub><pmid>39376364</pmid><doi>10.1007/s12070-024-04889-0</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-0884-7401</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2231-3796
ispartof Indian journal of otolaryngology, and head, and neck surgery, 2024-10, Vol.76 (5), p.4479-4486
issn 2231-3796
0973-7707
language eng
recordid cdi_proquest_miscellaneous_3114153795
source SpringerLink Journals - AutoHoldings
subjects Head and Neck Surgery
Medicine
Medicine & Public Health
Oral cancer
Original Article
Otorhinolaryngology
Squamous cell carcinoma
title Outcome of Upfront Surgically Resected Patients of Oral Tongue Squamous Cell Carcinoma and Factors Affecting it: Experience from Tertiary Care Facility in North India
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T00%3A47%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcome%20of%20Upfront%20Surgically%20Resected%20Patients%20of%20Oral%20Tongue%20Squamous%20Cell%20Carcinoma%20and%20Factors%20Affecting%20it:%20Experience%20from%20Tertiary%20Care%20Facility%20in%20North%20India&rft.jtitle=Indian%20journal%20of%20otolaryngology,%20and%20head,%20and%20neck%20surgery&rft.au=Jain,%20Sumeet&rft.date=2024-10&rft.volume=76&rft.issue=5&rft.spage=4479&rft.epage=4486&rft.pages=4479-4486&rft.issn=2231-3796&rft.eissn=0973-7707&rft_id=info:doi/10.1007/s12070-024-04889-0&rft_dat=%3Cproquest_cross%3E3114153795%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3113371218&rft_id=info:pmid/39376364&rfr_iscdi=true